These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression. Jann MW; Cohen LJ Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582 [TBL] [Abstract][Full Text] [Related]
4. [The value of pharmacogenetic tests in antidepressive medication therapy]. Kirchheiner J; Sasse J; Roots I; Brockmöller J; Bauer M Nervenarzt; 2005 Nov; 76(11):1340-54. PubMed ID: 15864514 [TBL] [Abstract][Full Text] [Related]
6. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments? Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920 [No Abstract] [Full Text] [Related]
8. The future of antidepressant pharmacogenetics is arriving. Introduction. Holsboer F Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):996-8. PubMed ID: 16002199 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic considerations for current state-of-the-art antidepressants. Wyska E Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279 [No Abstract] [Full Text] [Related]
10. Current therapy and future treatment strategies for depression (Paris, January 2003). Moret C J Psychopharmacol; 2003 Sep; 17(3):337-41. PubMed ID: 14513927 [No Abstract] [Full Text] [Related]
11. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. Narasimhan S; Lohoff FW Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of depression: the current state and perspectives of the development of pharmacological studies]. Ivanetz NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):108-16. PubMed ID: 25614913 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics of depression in elderly patients]. Monnin J; Haffen E; Sechter D; Vandel P Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and psychoactive drug therapy: ready for the patient? Steimer W Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233 [TBL] [Abstract][Full Text] [Related]
16. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Fabbri C; Porcelli S; Serretti A Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125 [TBL] [Abstract][Full Text] [Related]
17. Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing. Bishop JR Clin Transl Sci; 2021 Jul; 14(4):1206-1209. PubMed ID: 34058073 [No Abstract] [Full Text] [Related]
18. Antidepressant pharmacodynamics, pharmacokinetics, and drug interactions. Ereshefsky L Geriatrics; 1998 Dec; 53 Suppl 4():S22-33. PubMed ID: 9861902 [No Abstract] [Full Text] [Related]
19. Is Pharmacogenetics Useful in Antidepressant Treatment? Fabbri C; Serretti A Clin Pharmacol Ther; 2019 Nov; 106(5):916-918. PubMed ID: 31584716 [No Abstract] [Full Text] [Related]
20. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade. Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]